Results for tag: "Simponi Aria"

Simponi Aria is a biologic drug used to treat immune disorders such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is a monoclonal antibody that works by blocking the action of tumor necrosis factor (TNF), a protein that plays a role in inflammation. Simponi Aria is administered via subcutaneous injection and is available in both single-dose and multi-dose vials. The Simponi Aria market is a subset of the larger immune disorders drugs market. It is a rapidly growing market, driven by the increasing prevalence of immune disorders and the need for effective treatments. The market is highly competitive, with a number of major players offering similar products. Some of the companies in the Simponi Aria market include Johnson & Johnson, AbbVie, Pfizer, Merck, and Novartis. Show Less Read more